U.S. flag

An official website of the United States government

NM_000520.6(HEXA):c.8G>C (p.Ser3Thr) AND not specified

Germline classification:
Likely benign (2 submissions)
Last evaluated:
Aug 4, 2022
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000781461.11

Allele description [Variation Report for NM_000520.6(HEXA):c.8G>C (p.Ser3Thr)]

NM_000520.6(HEXA):c.8G>C (p.Ser3Thr)

Gene:
HEXA:hexosaminidase subunit alpha [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
15q23
Genomic location:
Preferred name:
NM_000520.6(HEXA):c.8G>C (p.Ser3Thr)
HGVS:
  • NC_000015.10:g.72375965C>G
  • NG_009017.2:g.5215G>C
  • NM_000520.6:c.8G>CMANE SELECT
  • NM_001318825.2:c.8G>C
  • NP_000511.2:p.Ser3Thr
  • NP_001305754.1:p.Ser3Thr
  • NC_000015.9:g.72668306C>G
  • NM_000520.4:c.8G>C
  • NM_000520.5:c.8G>C
  • NR_134869.3:n.50G>C
Protein change:
S3T
Links:
dbSNP: rs374524755
NCBI 1000 Genomes Browser:
rs374524755
Molecular consequence:
  • NM_000520.6:c.8G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001318825.2:c.8G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NR_134869.3:n.50G>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000885566ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
criteria provided, single submitter

(ARUP Molecular Germline Variant Investigation Process)
Likely benign
(Oct 8, 2018)
germlineclinical testing

Citation Link,

SCV000919498Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Likely benign
(Aug 4, 2022)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Carrier screening in the era of expanding genetic technology.

Arjunan A, Litwack K, Collins N, Charrow J.

Genet Med. 2016 Dec;18(12):1214-1217. doi: 10.1038/gim.2016.30. Epub 2016 Apr 7.

PubMed [citation]
PMID:
27054707

Screening for Tay-Sachs disease carriers by full-exon sequencing with novel variant interpretation outperforms enzyme testing in a pan-ethnic cohort.

Cecchi AC, Vengoechea ES, Kaseniit KE, Hardy MW, Kiger LA, Mehta N, Haque IS, Moyer K, Page PZ, Muzzey D, Grinzaid KA.

Mol Genet Genomic Med. 2019 Aug;7(8):e836. doi: 10.1002/mgg3.836. Epub 2019 Jul 10.

PubMed [citation]
PMID:
31293106
PMCID:
PMC6687860

Details of each submission

From ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories, SCV000885566.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV000919498.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

Variant summary: HEXA c.8G>C (p.Ser3Thr) results in a conservative amino acid change in the encoded protein sequence. Four of four in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00046 in 250174 control chromosomes and was also observed predominantly in the Ashkenazi Jewish subpopulation at a frequency of 0.0056 (56/10048). This frequency is about 4 times the estimated maximal expected allele frequency of a pathogenic HEXA variant (0.0013975), suggesting this is likely a benign polymorphism found primarily in populations of Ashkenazi Jewish origin. c.8G>C has been reported in the literature in individuals not affected with Tay-Sachs Disease. These reports do not provide unequivocal conclusions about association of the variant with Tay-Sachs Disease. Two publications showed that inviduals carrying this variant have normal HEXA activity. Seven clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation (likely benign n=6, VUS n=1). Based on the evidence outlined above, the variant was classified as likely benign.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 20, 2024